Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

May 17, 2023

SELL
$5.69 - $10.07 $31,295 - $55,385
-5,500 Reduced 25.35%
16,200 $128 Million
Q3 2022

May 16, 2023

BUY
$7.17 - $13.87 $73,134 - $141,474
10,200 Added 88.7%
21,700 $209 Million
Q1 2022

Apr 21, 2022

SELL
$10.92 - $16.41 $152,880 - $229,740
-14,000 Reduced 54.9%
11,500 $148,000
Q4 2021

Feb 03, 2022

SELL
$15.81 - $18.99 $602,361 - $723,518
-38,100 Reduced 59.91%
25,500 $407,000
Q3 2021

Oct 21, 2021

SELL
$12.68 - $17.79 $300,516 - $421,623
-23,700 Reduced 27.15%
63,600 $1.02 Million
Q2 2021

Aug 13, 2021

BUY
$12.95 - $15.41 $130,795 - $155,641
10,100 Added 13.08%
87,300 $1.21 Million
Q1 2021

Apr 30, 2021

BUY
$14.42 - $21.39 $529,214 - $785,013
36,700 Added 90.62%
77,200 $1.13 Million
Q4 2020

Feb 16, 2021

SELL
$16.56 - $18.94 $139,104 - $159,096
-8,400 Reduced 17.18%
40,500 $704,000
Q3 2020

Nov 12, 2020

SELL
$17.41 - $19.89 $113,165 - $129,285
-6,500 Reduced 11.73%
48,900 $897,000
Q2 2020

Aug 12, 2020

BUY
$14.43 - $19.16 $54,834 - $72,808
3,800 Added 7.36%
55,400 $989,000
Q1 2020

May 12, 2020

SELL
$11.67 - $22.53 $150,543 - $290,637
-12,900 Reduced 20.0%
51,600 $837,000
Q4 2019

Jan 27, 2020

BUY
$16.33 - $21.37 $382,121 - $500,058
23,400 Added 56.93%
64,500 $1.16 Million
Q3 2019

Oct 22, 2019

BUY
$16.3 - $23.37 $669,930 - $960,507
41,100 New
41,100 $833,000

Others Institutions Holding CHRS

About Coherus BioSciences, Inc.


  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $122M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.